Back HCV Treatment

AASLD 2017: Model Shows Hepatitis C Treatment is Cost-Effective in Japan

Treatment of chronic hepatitis C with direct-acting antivirals can lead to substantial savings by preventing the development of liver failure and liver cancer, according to a mathematical modeling study presented at the AASLD Liver Meeting in October in Washington, DC.


Read more: